Drug Profile
ER 127528
Alternative Names: ER127528Latest Information Update: 17 Nov 2006
Price :
$50
*
At a glance
- Originator Eisai Co Ltd
- Class Antidementias; Neuroprotectants; Small molecules
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 23 Apr 2001 Preclinical development for Alzheimer's disease in Japan (Unknown route)